About Ecnoglutide Ecnoglutide injection, originally discovered and developed by Sciwind Biosciences, is the world's first approved cAMP-biased GLP-1 receptor agonist enhancing clinical efficacy and accessibility
As a tripeptide with antioxidant properties and melanogenesis-regulating effects, it strengthens your bodys own defenses against ageing
GLP-1 Supplements like prebiotic fiber, probiotics, berberine, green tea extract, and whey protein can further boost natural GLP-1 signaling
Ben-Othman N, Vieira A, Courtney M, Record F, Gjernes E, Avolio F, Hadzic B, Druelle N, Napolitano T, Navarro-Sanz S, Silvano S, Al-Hasani K, Pfeifer A, Lacas-Gervais S, Leuckx G, Marroqu L, Thvenet J, Madsen OD, Eizirik DL, Heimberg H, Kerr-Conte J, Pattou F, Mansouri A, Collombat P